Age-related macular degeneration (AMD) is the leading cause of blindness among Americans over the age of 65. In the condition, the macula, the portion of the retina which allows for sharp, central vision, gradually degenerates, leading to progressive loss of eyesight. As the number of individuals in this age group continues to rise, it is estimated that the number of those with AMD will double by the year 2050. Current treatment options for the disease are limited and include anti-angiogenic drugs and laser therapy to address abnormal blood vessels and block the development of new ones. However, a new revolutionary technology is now offering AMD patients a new, more promising treatment alternative.
For those facing very advanced stages of macular degeneration, the options to improve vision and regain some quality of life are nearly non-existent. However, it is exactly this group which stands to benefit from CentraSight.
CentraSight is the very first treatment option of its kind. In this procedure, a tiny telescope is implanted inside the eye. The telescope enlarges objects that would be seen in the AMD affected straight-ahead, or central, vision. These images are then projected onto the healthy portion of the retina, allowing patients to do something as simple as watch TV or make out facial expressions. In trial studies, CentraSight has been shown to improve quality of life. Patients are able to regain some of their independence and participate in everyday activities that were previously impossible.
The first step to receiving a CentraSight implant is to gain qualification from a retinal specialist. These doctors deal frequently with AMD and other conditions affecting this part of the eye. Before approval can be obtained, prospective patients will need to undergo a medical and vision evaluation. Additionally, it will be important to determine a patient’s expectations of achievable results to ensure that these are not out of proportion with actual, obtainable goals.
Once approved, patients will be referred to an eye surgeon who will implant the device in an outpatient procedure. For those in the Baton Rouge area, this physician is Dr. Thomas Stuckey of Eye Specialists of Louisiana. Dr. Stuckey is currently the only surgeon in the capital region to specialize in this advanced technology. Follow-up after the procedure will include visits with a vision specialist as patients become accustomed to the new device.
AMD can be a frightening disease and one that gradually takes a devastating toll on quality of life. Those in the later stages have few treatment options. The goal of CentraSight is to address the particular concerns that come with advanced AMD and to give back some of what it has taken from its victims.
If you are in the Baton Rouge area and have a loved one who may suffer from AMD or have been diagnosed yourself, contact Eye Specialists of Louisiana to learn more about this new, revolutionary treatment. Simply click here, or call our office directly at (225) 768-7777.
Ophthalmologists Dr. David M. Dragon, M.D., Dr. Tim D. Johnson, M.D., and Dr. Thomas C. Stuckey III, M.D., serving Baton Rouge, Baker, Zachary, Prairieville, Denham Springs, Port Allen, Gonzales, Clinton, Walker, Plaquemine, Donaldsonville and the surrounding area.